LMR与妇科恶性肿瘤预后的研究进展

doi:10.11904/j.issn.1002-3070.2017.06.017

Abstract

Abstract: A large number of medical studies have confirmed that inflammation with occurrence and development of tumor are closely related.In recent years,it has been confirmed and described that the tumor-related inflammatory response plays an important role in the prognosis of tumor.Furthermore,the tumor-related inflammatory response can be reflected by the patient's neutrophils,lymphocytes,monocytes and other peripheral blood indicators,such as peripheral blood lymphocytes and mononuclear cells ratio(LMR).LMR plays an important role in the diagnosis and prognosis of tumor patients.In many studies from China and other countries,LMR has been described digestive,blood and other systems of malignant tumors,which it plays an important role in the prognosis.There is little domestic and foreign report on the research progress of LMR on the gynecological reproductive system.Therefore,this article reviews the effect of LMR on the prognosis of common gynecological malignancies.

Key words: Lymphocyte to monocyte ratio, Gynecological tumors, Prognosis, Inflammatory factor

CLC Number:

R737

TANG Mengmeng, LIU Tianbo, WANG Jing. Recent advances in prognosis of LMR associated with gynecological malignancies[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 569-572.

References

1 Virchow R.An address on the value of pathological experiments[J].Br Med J,1881,2(1075):198-203.
2 Diakos CI,Charles KA,McMillan DC,et al.Cancer-related inflammation and treatment effectiveness[J].Lancet Oncol,2014,15(11):493-503.
3 Shalapour S,Karin M.Immunity,inflammation,and cancer:an eternal fight between good and evil[J].J Clin Invest,2015,125(9):3347-3355.
4 Chan JC,Chan DL,Diakos CI,et al.The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer[J].Ann Surg,2016,265(3):539-546.
5 Minami T,Shimizu N,Yamamoto Y,et al.Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma[J].J Immunother,2015,38(7):285-291.
6 Coulie PG,Van den Eynde BJ,van der Bruggen P,et al.Tumour antigens recognized by T lymphocytes:at the core of cancer immunotherapy[J].Nat Rev Cancer,2014,14(2):135-146.
7 Guo YH,Sun HF,Zhang YB,et al.The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer:a meta-analysis[J].Oncotarget,2017,8(12):20011-20024.
8 Ray-Coquard I,Cropet C,Van Glabbeke M,et al.Lymphopenia as a prognostic factor for overall survival in advanced carcinomas,sarcomas,and lymphomas[J].Cancer Res,2009,69(13):5383-5391.
9 Chanmee T,Ontong P,Konno K,et al.Tumor-associated macrophages as major players in the tumor microenvironment[J].Cancers(Basel),2014,6(3):1670-1690.
10 Szkandera J,Gerger A,Liegl-Atzwanger B,et al.The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas[J].Int J Cancer,2014,135(2):362-370.
11 Hu S,Zou Z,Li H,et al.The preoperative peripheral blood monocyte count is associated with liver metastasis and overall survival in colorectal cancer patients[J].PLoS One,2016,11(6):e0157486.
12 Kumagai S,Marumo S,Shoji T,et al.Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma[J].Lung Cancer,2014,85(3):457-464.
13 Nishijima TF,Muss HB,Shachar SS,et al.Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors:A systematic review and meta-analysis[J].Cancer Treat Rev,2015,41(10):971-978.
14 Gu L,Li H,Chen L,et al.Prognostic role of lymphocyte to monocyte ratio for patients with cancer:evidence from a systematic review and meta-analysis[J].Oncotarget,2016,7(22):31926-31942.
15 Lin GN,Peng JW,Liu DY,et al.Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy[J].Tumour Biol,2014,35(11):10849-10854.
16 Aizawa M,Gotohda N,Takahashi S,et a1.Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer[J].World J Surg,2011,35(12):2717-2722.
17 Kitayama J,Yasuda K,Kawai K,et a1.Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer[J].Radiat Oncol,2010,5(1):47.
18 Chen L,Zhang F,Sheng XG,et a1.Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgery[J].Onco Targets Ther,2015,8:1355-1362.
19 Granados López AJ,López JA.Multistep model of cervical cancer:participation of miRNAs and coding genes[J].Int J Mol Sci,2014,15(9):15700-15733.
20 Fang H,Shuang D,Yi Z,et a1.Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients[J].Biomed Pharmacother,2016,83:64-69.
21 Yang Y,Song KL,Chang H.Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer[J].Diagn Pathol,2014,9(1):1-5.
22 Siegel RL,Miller KD,Jemal A.Cancer statistics,2017[J].CA Cancer J Clin,2017,67(1):7-30.
23 Zhu JY,Liu CC,Wang L,et a1.Peripheral blood lymphocyte-to-monocyte ratio as a prognostic factor in advanced epithelial ovarian cancer:a multicenter retrospective study[J].J Cancer,2017,8(5):737-743.
24 Eo WK,Kwon S,Koh SB,et al.The lymphocyte-monocyte ratio predicts patient survival and aggressiveness of endometrial cancer[J].J Cancer,2016,7(5):538-545.
25 Gao Y,Dai M,Liu H,et al.Diagnostic value of circulating miR-21:An update meta-analysis in various cancers and validation in endometrial cancer[J].Oncotarget,2016,7(42):68894-68908.

[1]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[2]	FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.
[3]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[4]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[5]	LU Jiaoyun, ZHANG Qingyuan. Advances in laboratory markers in the prognosis of diffuse large B-cell lymphoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 183-187.
[6]	ZHAO Fengjuan, WANG Qi, REN Yunhong, WEI Jueling, LI Lequn, ZHAO Xinhua, TANG Juan, YOU Xuemei. Changes of serum CRP and hs-CRP levels in patients with liver cancer and depression and their influence on prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 27-33.
[7]	ZHANG Fengchun, JIANG Ying, LIU Zhaonan, YAN Ningning, CUI Hongquan, XU Yingchun. Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indicators in gastric cancer patients after radical resection [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 34-39.
[8]	MA Jianli, ZHANG Minghui, JI Hongfei, XU Xiangying. Clinical significance of combined detection of PD-L1 protein and CD8⁺TILs in resected lung adenocarcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 40-46.
[9]	YANG Hongbo, SHI Jie, YE Yong, LI Wencheng, DENG Zhaoping. Expression of COL5A2 in bladder cancer tissues and its correlation with clinicopathological features and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 52-56.
[10]	WANG Yalong, LYU Zhangyan, ZHANG Fan, FENG Xiaoshuang, WEI Luopei, LI Xin, WEN Yan, GAO Yushun, XUE Qi, GAO Shugeng, TAN Fengwei. Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 520-526.
[11]	TANG Shuli, HE Kuangbang, ZHANG Chunhui, CHENG Jianan, ZHANG Yanqiao. Expression of miR-320a and CYLD in gastric cancer and its relationship with clinicopathological characteristics and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 538-544.
[12]	XIAO Hongwei, CHEN Sheng, WANG Yanliang, SU Xueliang. The prognostic and influence factors analysis of transanal local resection for stage T₁ rectal cancer with the distance from anal margin ≤8 cm [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 545-549.
[13]	WANG Yiran, HUANG Wei, YIN Lei, LIU Lin, ZHOU Xiaoping, NIU Xingjian, YANG Yue, AN Weiwei, JI Hongfei. The ratio of neutrophil to lymphocyte in the efficacy and prognosis of concurrent chemoradiotherapy in patients with cervical cancer and its clinical significance [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 404-409.
[14]	LI Meiyan, CHEN Yongxue, HOU Junde. Effects of Leptin,VEGF and different anesthesia methods on prognosis of endometrial cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 426-431.
[15]	HAN Teng, TANG Liping. Advances in the relationship between the PD-L1 expression and the prognosis of gynecologic malignancies [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 468-470.

Recent advances in prognosis of LMR associated with gynecological malignancies

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments